166
Views
9
CrossRef citations to date
0
Altmetric
Research Reports

Internuclear Ophthalmoplegia Associated with Anti-TNFα Medication

, BMedSci Orthoptics (Hons) & , PhD, FRCP
Pages 30-32 | Received 12 Sep 2014, Accepted 08 Dec 2014, Published online: 19 Mar 2015
 

Abstract

Aim: To describe the presentation of an internuclear ophthalmoplegia (INO) associated with the use of anti-tumor necrosis factor α (anti-TNFα) medication.

Methods: A case report of a woman, aged 27 years, who developed facial numbness, blurred vision, and diplopia on right gaze. She had a history of Crohn’s disease, which was being treated by the anti-TNFα drug, adalimumab. On examination, a left INO was found.

Treatment: The patient was prescribed a short course of corticosteroids and adalimumab treatment was discontinued.

Results: Magnetic resonance imaging demonstrated typical demyelinating lesions including one responsible for the INO. Following a short course of corticosteroids and the discontinuation of the adalimumab treatment, the INO resolved, resulting in a swift improvement of ocular motility over a 2-week period.

Conclusion: Anti-TNFα therapies have been associated with the development of demyelinating diseases. The presentation of a brainstem syndrome in a patient on anti-TNFα therapy should lead to investigation for central nervous system demyelination and cessation of the medication.

Acknowledgments

Case written in line with the declaration of Helsinki 1975.

Declaration of interest

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.